| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.33 | 0.08 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.34 | 0.08 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |